Roll out of personalised CAR-T cancer therapies

Hundreds more people with cancer are now set to receive personalised CAR-T therapies. The immunotherapies, which use a patient’s own immune cells to create a tailored treatment, will immediately be made available through the Cancer Drugs Fund (CDF) for people with one of two forms of blood cancer. CAR-T, or chimeric antigen receptor T-cell therapy, involves reprogramming the patient’s own immune system and using immune cells to target their cancer.

Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.